Search - tctmd.com

Displaying 1 - 20 of 81

Sort: Relevancy | Date

News Conference News ESC 2025

DanGer Shock: Impella Tied to Better Survival Even 10 Years Later

Caitlin E. Cox

September 08, 2025

News Conference News ESC 2025

HELP-MI SWEDEHEART: Routine H. Pylori Screening Doesn’t Lessen Bleeding After MI

Todd Neale

September 03, 2025

News Conference News ESC 2025

ICD No Help for High-Risk, Post-MI Patients With Moderately Reduced EF

Todd Neale

September 02, 2025

Presentation ESC 2025

Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial

Presenter: Robin Hofmann

August 31, 2025

News Conference News ESC 2025

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Michael O'Riordan

August 31, 2025

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

News Conference News ESC 2024

AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions

Caitlin E. Cox

September 12, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

Presentation ESC 2023

Functional versus Culprit only Revascularization in Elderly Patients with Myocardial Infarction and Multivessel Disease

Presenter: Simone Biscaglia

August 28, 2023

Presentation ESC 2023

Extracorporeal life support for acute myocardial infarction complicated by cardiogenic shock: ECLS-SHOCK

Presenter: Holger Thiele

August 28, 2023

News Conference News ESC 2023

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

Caitlin E. Cox

August 26, 2023

News Conference News ESC 2023

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

Michael O'Riordan

August 26, 2023

Presentation ESC 2022

Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction

Presenter: John H. Alexander

August 28, 2022

News Conference News ESC 2022

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Shelley Wood

August 28, 2022

News Conference News ESC 2022

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

Todd Neale

August 28, 2022

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Shelley Wood

August 28, 2021

News Conference News ESC 2021

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

Michael O'Riordan

August 27, 2021

News Daily News ESC 2021

Colchicine in STEMI Fails to Reduce Infarct Size: COVERT-MI

Caitlin E. Cox

August 26, 2021

Advertisement

DanGer Shock: Impella Tied to Better Survival Even 10 Years Later

HELP-MI SWEDEHEART: Routine H. Pylori Screening Doesn’t Lessen Bleeding After MI

ICD No Help for High-Risk, Post-MI Patients With Moderately Reduced EF

Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Functional versus Culprit only Revascularization in Elderly Patients with Myocardial Infarction and Multivessel Disease

Extracorporeal life support for acute myocardial infarction complicated by cardiogenic shock: ECLS-SHOCK

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

Polypill Bests Usual Care in Patients With Recent MI: SECURE

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

Colchicine in STEMI Fails to Reduce Infarct Size: COVERT-MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content